Romain-David Seban - Search Results

Year	Number of Results
2016	1
2017	3
2018	3
2019	6
2020	9
2021	12
2022	3

1

The Role of Cost-Effectiveness Analysis in Patient-Centered Cancer Care in the Era of Precision Medicine.

Toscano F, Vera A, Kim E, Golinelli D, Vila-Reyes H, Bteich F, Schernberg A, Seban RD, Yeh R, Dercle L. Toscano F, et al. Among authors: seban rd. Cancers (Basel). 2021 Aug 25;13(17):4272. doi: 10.3390/cancers13174272. Cancers (Basel). 2021. PMID: 34503082 Free PMC article.

2

Immune Response Visualized In Vivo by [18F]-FDG PET/CT after COVID-19 Vaccine.

Seban RD, Champion L, Deleval N, Richard C, Provost C. Seban RD, et al. Diagnostics (Basel). 2021 Apr 9;11(4):676. doi: 10.3390/diagnostics11040676. Diagnostics (Basel). 2021. PMID: 33918702 Free PMC article.

3

Imaging-guided precision medicine in non-resectable gastro-entero-pancreatic neuroendocrine tumors: A step-by-step approach.

Rozenblum L, Mokrane FZ, Yeh R, Sinigaglia M, Besson FL, Seban RD, Zadro C, Dierickx L, Chougnet CN, Partouche E, Revel-Mouroz P, Zhao B, Otal P, Schwartz LH, Dercle L. Rozenblum L, et al. Among authors: seban rd. Eur J Radiol. 2020 Jan;122:108743. doi: 10.1016/j.ejrad.2019.108743. Epub 2019 Nov 12. Eur J Radiol. 2020. PMID: 31783345 Review.

4

Immune-Related Erythema Nodosum Mimicking in Transit Melanoma Metastasis on [18F]-FDG PET/CT.

Seban RD, Vermersch C, Champion L, Bonsang B, Roger A, Ghidaglia J. Seban RD, et al. Diagnostics (Basel). 2021 Apr 22;11(5):747. doi: 10.3390/diagnostics11050747. Diagnostics (Basel). 2021. PMID: 33922013 Free PMC article.

5

¹⁸F-FDG PET/CT in Relapsed Endometrial Cancer Treated with Preoperative PD-1 Inhibitor Dostarlimab.

Seban RD, Donnadieu A, Journo G, Bidard FC, Richard C, Rouzier R, Champion L. Seban RD, et al. Diagnostics (Basel). 2021 Jul 28;11(8):1353. doi: 10.3390/diagnostics11081353. Diagnostics (Basel). 2021. PMID: 34441288 Free PMC article.

6

Spleen glucose metabolism on [¹⁸F]-FDG PET/CT: a dynamic double-edged biomarker predicting outcome in cancer patients.

Seban RD, Champion L, Schwartz LH, Dercle L. Seban RD, et al. Eur J Nucl Med Mol Imaging. 2021 Jul;48(8):2309-2311. doi: 10.1007/s00259-020-05126-w. Epub 2021 Jan 9. Eur J Nucl Med Mol Imaging. 2021. PMID: 33420612 No abstract available.

7

Editorial: Breakthrough in Imaging-Guided Precision Medicine in Oncology.

Shaw A, Seban RD, Besson FL, Vila-Reyes H, Ammari S, Mokrane FZ, Yeh R, Dercle L. Shaw A, et al. Among authors: seban rd. Front Oncol. 2022 May 18;12:908561. doi: 10.3389/fonc.2022.908561. eCollection 2022. Front Oncol. 2022. PMID: 35664770 Free PMC article. No abstract available.

8

Spleen Glucose Metabolism on [18F]-FDG PET/CT for Cancer Drug Discovery and Development cannot be Overlooked.

Seban RD, Synn S, Muneer I, Champion L, Schwartz LH, Dercle L. Seban RD, et al. Curr Cancer Drug Targets. 2021;21(11):944-952. doi: 10.2174/1568009621666210720143826. Curr Cancer Drug Targets. 2021. PMID: 34288841

9

Assessing immune response upon systemic RNA vaccination on [18F]-FDG PET/CT for COVID-19 vaccine and then for immuno-oncology?

Seban RD, Champion L, Yeh R, Schwartz LH, Dercle L. Seban RD, et al. Eur J Nucl Med Mol Imaging. 2021 Oct;48(11):3351-3352. doi: 10.1007/s00259-021-05468-z. Epub 2021 Jun 23. Eur J Nucl Med Mol Imaging. 2021. PMID: 34164727 Free PMC article. No abstract available.

10

Metabolic Response by 18F-FDG PET/CT in Metastatic Malignant Struma Ovarii Treated With Targeted Therapies.

Seban RD, Bozec L, Nascimento-Leite C, Champion L. Seban RD, et al. Clin Nucl Med. 2021 Jan;46(1):52-54. doi: 10.1097/RLU.0000000000003374. Clin Nucl Med. 2021. PMID: 33181745

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results